Investing
Anticipating Alcoa’s Stock Performance Ahead of Earnings Release
“`html Alcoa (NYSE:AA) is scheduled to report its first quarter earnings on April 16, 2025, with expected revenues of approximately $3.6 billion, marking a ...
Favorable Outlook for Q2 Earnings as Major Bank Results Approach
The Q2 earnings season kicks off this week with nearly 100 companies expected to report, including 38 S&P 500 members. Major firms set to ...
Invest in E-commerce Expansion with Groupon and CarGurus
“`html In the first quarter of 2025, U.S. ecommerce sales grew 6.1% compared to the first quarter of 2024, representing around 16.2% of total ...
Analysts Project Significant Upside for Trevi Therapeutics (TRVI): Key Insights Revealed
Trevi Therapeutics, Inc. (TRVI) closed at $6.41, with a 3.9% gain over the last four weeks. Wall Street analysts set a mean price target ...
Marsh & McLennan Increases Dividend by 10% to $0.90 per Share
Marsh & McLennan Companies, Inc. (MMC) has announced a 10% increase in its quarterly dividend, raising the payout from 81.5 cents to 90 cents ...
China’s DUV Demand Boosts ASML Holding: Can Export Restrictions Hinder Growth?
ASML Holding reported that its sales to China made up 27% of total revenues for the first quarter of 2025, surpassing prior expectations of ...
Evaluating Navitas Semiconductor: Buy or Hold After a 246% Surge in 2025?
Navitas Semiconductor (NVTS) has achieved a remarkable 246% increase in stock price over the past three months, significantly surpassing growth in the Electronics – ...
AG Sees Year-over-Year Surge in Q2 Silver-Equivalent Output and Upgrades Forecast
First Majestic Silver Corp. (AG) reported total production of 7.9 million silver-equivalent (AgEq) ounces in the second quarter of 2025, including 3.7 million silver ...
Exploring the Long-Term Investment Potential of Jazz Pharmaceuticals
Jazz Pharmaceuticals (NASDAQ: JAZZ) is currently trading at approximately $110, down 11% year-to-date, following the European Commission’s conditional Marketing Authorization for Ziihera (zanidatamab) for ...
Is Now the Right Moment to Invest in SoFi Technologies for Future Growth?
SoFi Technologies (SOFI) has recently reached a 52-week high of $20 per share and has gained over 30% in 2025, increasing more than 200% ...
